A case of acute hyperammonemic encephalopathy after initiation of 5-fluorouracil chemotherapy-Reference-Cited by-同舟云学术

A case of acute hyperammonemic encephalopathy after initiation of 5-fluorouracil chemotherapy

Published:2022-12-19 Issue: Volume:1 Page:11
ISSN:2835-253X
Container-title:American Journal of Pharmacotherapy and Pharmaceutical Sciences
language:en
Short-container-title:AJPPS

Author:

Daly Timothy¹,Prenatt Zarian¹,Sagin Hannah¹,Wen Sally¹,Shah Kashyap²,Proothi Subhash³,Hehar Prabhdeep⁴

Affiliation:

1. Department of Internal Medicine, SLUHN, Bethlehem, Pennsylvania, United States,

2. Department of Cardiology, SLUHN, Bethlehem, Pennsylvania, United States,

3. Department of Hematology/Oncology, SLUHN, Bethlehem, Pennsylvania, United States,

4. Department of Anesthesia/Critical Care, SLUHN, Bethlehem, Pennsylvania, United States,

Abstract

5-fluorouracil is a chemotherapeutic agent that has been used for decades to treat a number of neoplasms. It has a number of adverse effects; however, we present a case of a seldom reported side effect in hyperammonemic encephalopathy that should be considered in patients presenting with altered mental status shortly after starting therapy.

Publisher

Scientific Scholar

Reference9 articles.

1. 5-fluorouracil treatment induces characteristic T>G mutations in human cancer;Christensen;Nat Commun,2019

2. 5-fluorouracil rechallenge after 5-fluorouracil-induced hyperammonemic encephalopathy;Boilève;Anticancer Drugs,2019

3. 5-fluorouracil-induced hyperammonaemic encephalopathy: A French national survey;Boilève;Eur J Cancer,2020

4. Fluorouracil-induced hyperammonemia in a patient with colorectal cancer;Thomas;Anticancer Res,2015

5. Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemia;Nishikawa;Cancer Chemother Pharmacol,2017